Annual CFO
-$158.42 M
+$198.24 M+55.58%
31 December 2023
Summary:
PTC Therapeutics annual cash flow from operations is currently -$158.42 million, with the most recent change of +$198.24 million (+55.58%) on 31 December 2023. During the last 3 years, it has risen by +$35.65 million (+18.37%). PTCT annual CFO is now -1474.26% below its all-time high of -$10.06 million, reached on 31 December 2017.PTCT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$76.99 M
-$5.54 M-7.75%
30 September 2024
Summary:
PTC Therapeutics quarterly cash flow from operations is currently -$76.99 million, with the most recent change of -$5.54 million (-7.75%) on 30 September 2024. Over the past year, it has dropped by -$62.47 million (-430.28%). PTCT quarterly CFO is now -208.81% below its all-time high of $70.76 million, reached on 31 March 2024.PTCT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$177.97 M
-$62.47 M-54.09%
30 September 2024
Summary:
PTC Therapeutics TTM cash flow from operations is currently -$177.97 million, with the most recent change of -$62.47 million (-54.09%) on 30 September 2024. Over the past year, it has increased by +$46.12 million (+20.58%). PTCT TTM CFO is now -2124.71% below its all-time high of $8.79 million, reached on 30 September 2018.PTCT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTCT Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +55.6% | -430.3% | +20.6% |
| 3 y3 years | +18.4% | -50.4% | +27.9% |
| 5 y5 years | -473.1% | -396.7% | -71.8% |
PTCT Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +55.6% | -208.8% | +53.6% | -206.0% | +50.1% |
| 5 y | 5 years | -473.1% | +55.6% | -208.8% | +53.6% | -206.0% | +50.1% |
| alltime | all time | -1474.3% | +55.6% | -208.8% | +53.6% | -2124.7% | +50.1% |
PTC Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$76.99 M(+7.8%) | -$177.97 M(+54.1%) |
| June 2024 | - | -$71.45 M(-201.0%) | -$115.50 M(+98.6%) |
| Mar 2024 | - | $70.76 M(-170.6%) | -$58.17 M(-63.3%) |
| Dec 2023 | -$158.42 M(-55.6%) | -$100.29 M(+590.7%) | -$158.42 M(-29.3%) |
| Sept 2023 | - | -$14.52 M(+2.8%) | -$224.09 M(-9.5%) |
| June 2023 | - | -$14.12 M(-52.1%) | -$247.62 M(-14.2%) |
| Mar 2023 | - | -$29.49 M(-82.2%) | -$288.74 M(-19.0%) |
| Dec 2022 | -$356.65 M(+41.9%) | -$165.96 M(+336.2%) | -$356.65 M(+37.4%) |
| Sept 2022 | - | -$38.05 M(-31.1%) | -$259.53 M(-4.8%) |
| June 2022 | - | -$55.24 M(-43.3%) | -$272.68 M(+9.7%) |
| Mar 2022 | - | -$97.40 M(+41.5%) | -$248.58 M(-1.1%) |
| Dec 2021 | -$251.33 M(+29.5%) | -$68.84 M(+34.5%) | -$251.33 M(+1.8%) |
| Sept 2021 | - | -$51.19 M(+64.4%) | -$246.86 M(+46.1%) |
| June 2021 | - | -$31.14 M(-68.9%) | -$169.01 M(-20.5%) |
| Mar 2021 | - | -$100.16 M(+55.6%) | -$212.67 M(+9.6%) |
| Dec 2020 | -$194.07 M(+96.7%) | -$64.37 M(-341.4%) | -$194.07 M(+38.7%) |
| Sept 2020 | - | $26.66 M(-135.6%) | -$139.91 M(-23.2%) |
| June 2020 | - | -$74.81 M(-8.3%) | -$182.07 M(+32.1%) |
| Mar 2020 | - | -$81.55 M(+699.1%) | -$137.78 M(+39.7%) |
| Dec 2019 | -$98.64 M(+256.9%) | -$10.21 M(-34.2%) | -$98.64 M(-4.8%) |
| Sept 2019 | - | -$15.50 M(-49.2%) | -$103.58 M(+22.3%) |
| June 2019 | - | -$30.52 M(-28.0%) | -$84.70 M(+56.3%) |
| Mar 2019 | - | -$42.41 M(+180.1%) | -$54.17 M(+96.0%) |
| Dec 2018 | -$27.64 M | -$15.14 M(-548.4%) | -$27.64 M(-414.5%) |
| Sept 2018 | - | $3.38 M(>+9900.0%) | $8.79 M(-184.9%) |
| June 2018 | - | $3000.00(-100.0%) | -$10.36 M(-449.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$15.88 M(-174.6%) | $2.96 M(-129.4%) |
| Dec 2017 | -$10.06 M(-90.3%) | $21.29 M(-235.0%) | -$10.06 M(-77.5%) |
| Sept 2017 | - | -$15.77 M(-218.4%) | -$44.67 M(-15.7%) |
| June 2017 | - | $13.32 M(-146.1%) | -$52.98 M(-41.7%) |
| Mar 2017 | - | -$28.90 M(+117.0%) | -$90.88 M(-12.2%) |
| Dec 2016 | -$103.57 M(-16.7%) | -$13.32 M(-44.7%) | -$103.57 M(-14.1%) |
| Sept 2016 | - | -$24.07 M(-2.1%) | -$120.58 M(-3.0%) |
| June 2016 | - | -$24.59 M(-40.9%) | -$124.27 M(-4.0%) |
| Mar 2016 | - | -$41.59 M(+37.1%) | -$129.50 M(+4.2%) |
| Dec 2015 | -$124.34 M(+117.1%) | -$30.33 M(+9.3%) | -$124.34 M(+21.9%) |
| Sept 2015 | - | -$27.76 M(-6.9%) | -$102.00 M(+11.8%) |
| June 2015 | - | -$29.82 M(-18.1%) | -$91.27 M(+13.7%) |
| Mar 2015 | - | -$36.42 M(+355.7%) | -$80.26 M(+40.1%) |
| Dec 2014 | -$57.27 M(+22.1%) | -$7.99 M(-53.1%) | -$57.27 M(-10.1%) |
| Sept 2014 | - | -$17.04 M(-9.4%) | -$63.74 M(+22.9%) |
| June 2014 | - | -$18.81 M(+40.0%) | -$51.88 M(-1.2%) |
| Mar 2014 | - | -$13.44 M(-7.1%) | -$52.51 M(+11.9%) |
| Dec 2013 | -$46.92 M(-2.1%) | -$14.46 M(+179.4%) | -$46.92 M(+7.9%) |
| Sept 2013 | - | -$5.18 M(-73.4%) | -$43.50 M(-2.3%) |
| June 2013 | - | -$19.43 M(+147.7%) | -$44.52 M(+13.6%) |
| Mar 2013 | - | -$7.85 M(-28.9%) | -$39.20 M(-18.2%) |
| Dec 2012 | -$47.93 M(+130.8%) | -$11.04 M(+78.1%) | -$47.93 M(+29.9%) |
| Sept 2012 | - | -$6.20 M(-56.1%) | -$36.89 M(+20.2%) |
| June 2012 | - | -$14.12 M(-14.8%) | -$30.70 M(+85.2%) |
| Mar 2012 | - | -$16.58 M | -$16.58 M |
| Dec 2011 | -$20.77 M | - | - |
FAQ
- What is PTC Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for PTC Therapeutics?
- What is PTC Therapeutics annual CFO year-on-year change?
- What is PTC Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for PTC Therapeutics?
- What is PTC Therapeutics quarterly CFO year-on-year change?
- What is PTC Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for PTC Therapeutics?
- What is PTC Therapeutics TTM CFO year-on-year change?
What is PTC Therapeutics annual cash flow from operations?
The current annual CFO of PTCT is -$158.42 M
What is the all time high annual CFO for PTC Therapeutics?
PTC Therapeutics all-time high annual cash flow from operations is -$10.06 M
What is PTC Therapeutics annual CFO year-on-year change?
Over the past year, PTCT annual cash flow from operations has changed by +$198.24 M (+55.58%)
What is PTC Therapeutics quarterly cash flow from operations?
The current quarterly CFO of PTCT is -$76.99 M
What is the all time high quarterly CFO for PTC Therapeutics?
PTC Therapeutics all-time high quarterly cash flow from operations is $70.76 M
What is PTC Therapeutics quarterly CFO year-on-year change?
Over the past year, PTCT quarterly cash flow from operations has changed by -$62.47 M (-430.28%)
What is PTC Therapeutics TTM cash flow from operations?
The current TTM CFO of PTCT is -$177.97 M
What is the all time high TTM CFO for PTC Therapeutics?
PTC Therapeutics all-time high TTM cash flow from operations is $8.79 M
What is PTC Therapeutics TTM CFO year-on-year change?
Over the past year, PTCT TTM cash flow from operations has changed by +$46.12 M (+20.58%)